SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-23-000272
Filing Date
2023-03-03
Accepted
2023-03-03 08:30:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 e618320_f6pos-aslan.htm F-6 POS 65635
2 e618320_ex99-a2.htm EX-99.(A)(2) 160014
3 e618320_ex99-e.htm EX-99.(E) 2550
4 GRAPHIC image.jpg GRAPHIC 77586
  Complete submission text file 0001193805-23-000272.txt   336798
Mailing Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179
Business Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179 212-319-7600
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) CIK: 0001474274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: F-6 POS
SIC: 8880 American Depositary Receipts

Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Subject) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-224273 | Film No.: 23701739
SIC: 2834 Pharmaceutical Preparations